Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02607566 · ClinicalTrials.gov registry record · NA

Yoga as a Complementary Therapy for Adults With Type 2 Diabetes

A NA study of Diabetes Mellitus, Type 2, sponsored by The Miriam Hospital.

Completed
Registry status
NA
Development phase
48
Enrollment target
2
Study locations

NCT02607566 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by The Miriam Hospital. The registered enrollment target is 48 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02607566, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by The Miriam Hospital.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target
2
Study locations

Study Summary

This study will examine the feasibility and acceptability of a twice weekly yoga program for adults with type 2 diabetes. Changes in perceived stress, salivary cortisol, and HbA1c will also be examined.

Conditions Studied

Interventions

  • BEHAVIORAL Yoga
  • BEHAVIORAL Standard Exercise Program

Study Locations (2)

Rhode Island

  • The Miriam Hospital- CORO building - Providence
  • The Miriam Hospital - Providence

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2015-09
Est. Completion 2017-09
Phase NA

Sponsor

The Miriam Hospital

136 total trials

What the Registry Record Tells You About NCT02607566

The ClinicalTrials.gov registry entry for NCT02607566 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The listed sponsor is The Miriam Hospital, which has 136 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 2 interventions - of which Yoga is the first listed.

NCT02607566 reports 2 study locations spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT02607566 about?

NCT02607566 is a clinical study titled "Yoga as a Complementary Therapy for Adults With Type 2 Diabetes". This study will examine the feasibility and acceptability of a twice weekly yoga program for adults with type 2 diabetes. Changes in perceived stress, salivary cortisol, and HbA1c will also be examined.

What is the current status of trial NCT02607566?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2015-09. Estimated completion is 2017-09.

What conditions does trial NCT02607566 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT02607566?

The interventions under investigation include: Yoga (BEHAVIORAL), Standard Exercise Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT02607566?

This trial is sponsored by The Miriam Hospital, which has 136 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02607566 being conducted?

This trial has 2 study locations across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.